Variant report
Variant | nsv982191 |
---|---|
Chromosome Location | chr9:802956-805503 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000107104 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544455824 | chr9:802982-802983 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572067013 | chr9:802991-802992 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs13288334 | chr9:802999-803000 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs35396494 | chr9:803003-803004 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs13285288 | chr9:803008-803009 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs543356537 | chr9:803026-803027 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554307766 | chr9:803054-803055 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373173085 | chr9:803064-803065 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567611954 | chr9:803078-803079 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376376586 | chr9:803079-803080 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563242932 | chr9:803081-803082 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536663313 | chr9:803091-803092 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74910769 | chr9:803095-803096 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545815662 | chr9:803134-803135 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10976679 | chr9:803158-803159 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs143165833 | chr9:803183-803184 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180976795 | chr9:803187-803188 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78932677 | chr9:803236-803237 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531141314 | chr9:803237-803238 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551156492 | chr9:803269-803270 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368044409 | chr9:803291-803292 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377434205 | chr9:803342-803343 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571178433 | chr9:803350-803351 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551675079 | chr9:803367-803368 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs10976681 | chr9:803442-803443 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs76769238 | chr9:803445-803446 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184207683 | chr9:803471-803472 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146708045 | chr9:803473-803474 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574402669 | chr9:803475-803476 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10120425 | chr9:803481-803482 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs370736004 | chr9:803493-803494 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370873999 | chr9:803497-803498 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545678330 | chr9:803505-803506 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10815720 | chr9:803506-803507 | Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs541813974 | chr9:803507-803508 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562223151 | chr9:803522-803523 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530993592 | chr9:803567-803568 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567501044 | chr9:803579-803580 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10119680 | chr9:803606-803607 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs139374183 | chr9:803614-803615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142722840 | chr9:803619-803620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533700642 | chr9:803623-803624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547301510 | chr9:803625-803626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs60587682 | chr9:803634-803635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561054184 | chr9:803635-803636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565585733 | chr9:803657-803658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140268895 | chr9:803664-803665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181763385 | chr9:803673-803674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568161605 | chr9:803693-803694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186026096 | chr9:803694-803695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 21272361 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:794600-809600 | Weak transcription | Right Atrium | heart |
2 | chr9:801400-803600 | Flanking Active TSS | HUVEC | blood vessel |
3 | chr9:802200-805000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr9:802400-803000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
5 | chr9:802600-805000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr9:802800-804200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr9:802800-804200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr9:802800-805000 | Weak transcription | NHEK | skin |
9 | chr9:802800-808800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr9:802800-811600 | Weak transcription | HMEC | breast |
11 | chr9:803000-808800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr9:803600-804000 | Enhancers | HUVEC | blood vessel |
13 | chr9:804000-804600 | Flanking Active TSS | HUVEC | blood vessel |
14 | chr9:804200-804400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr9:804200-804400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr9:804400-804800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr9:804600-805800 | Enhancers | HUVEC | blood vessel |
18 | chr9:804800-805600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
19 | chr9:805000-805600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
20 | chr9:805000-805600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr9:805000-805600 | Enhancers | NHEK | skin |